Home - Translational Breast Cancer Research

Matched-pair long-term survival analysis of male and female patients with breast cancer: a population-based study

Observed OS of breast cancer patients diagnosed during 2002–2013 by sex. OS, overall survival.

Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives

Microenvironment and process of tumor initiation and progression. Reproduced from Terceiro et al. [2021] (40) with permission.

Internal mammary lymphadenopathy in breast cancer: a narrative review and update

Focused image of positron emission tomography-computed tomography with the presence of an abnormally enhancing internal mammary lymph node.

Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer

Overview of liquid biopsy analytes in blood. MDSCs, myeloid-derived suppressor cells; miRNA, microRNA; cirRNA, circular RNA; tRNA, transfer RNA; lncRNA, long non-coding RNA; rRNA, ribosomal RNA.

Reviewer of the Month (2024)

In 2024, TBCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Interviews with Outstanding Authors (2024)

In 2024, many TBCR authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspective and insightful view as authors.

Translational Breast Cancer Research is accepted for indexing in PubMed/PubMed Central (PMC)

On May 9, 2024, we received an official notice from the PubMed office that Translational Breast Cancer Research had been accepted for indexing by PubMed/PubMed Central (PMC), a free digital archive database of full-text journal literature in biomedical and life sciences. All articles published since 2022, beginning with Vol 3, will be fully indexed in PMC and accessible via PubMed, a search engine/database of biomedical citations and abstracts.

TBCR is officially indexed by Emerging Sources Citation Index (ESCI)

On March 20, 2024, a confirmation letter reached the editorial office of Translational Breast Cancer Research (TBCR) that the journal met the selection criteria necessary to be included in the Emerging Sources Citation Index. Articles published in TBCR since 2020, beginning with Vol 1, will be included in Emerging Sources Citation Index.

Annual Report of TBCR (2023)

Dear all,

We are pleased to share with you the 2023 annual report of Translational Breast Cancer Research (TBCR). In 2023, with the joint effort and support of all contributors, TBCR made great progress with the publication of 33 articles, and increased website pageviews and visitors. For more details, please see the following report.

‹ ›

Articles in Press

Past Issues

About tbcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: tbcr@amegroups.com
Copyright related enquiries:
Email: permissions@amegroups.com
Commercial sales contact (reprints, advertising, etc.):
Email: sales@amegroups.com

Case Report

Chemotherapy-induced neutropenia management in a patient with metastatic breast cancer and Shwachman-Diamond syndrome (SDS): a case report

Renee Morecroft, Constantine N. Logothetics, Stefan P. Tarnawsky, Andrew A. Davis

Translational Breast Cancer Research

2024;

(30 July 2024)

PDF Full Text (372) Reporting Checklist Peer Review File COI Form Open Access

Editorial Commentary

The optimal amino acid pattern for humans and its implications for nutrition of cancer patients

Rainer J. Klement

Translational Breast Cancer Research

2024;

(30 July 2024)

PDF Full Text (292) Peer Review File COI Form Open Access

Editorial Commentary

Activin A from primary breast tumors generates a pre-metastatic niche by inducing pulmonary fibrosis

Takuya Shirakihara, Akira Orimo

Translational Breast Cancer Research

2024;

(30 July 2024)

PDF Full Text (293) Peer Review File COI Form Open Access

Editorial Commentary

Toripalimab: a new torchlight illuminating the path for metastatic triple negative breast cancer?

Soeun Park, Sung Gwe Ahn

Translational Breast Cancer Research

2024;

(30 July 2024)

PDF Full Text (334) Peer Review File COI Form Open Access

Editorial Commentary

St. Gallen International Breast Cancer Conferences & Consensus

Beat Thürlimann

Translational Breast Cancer Research

2024;

(30 July 2024)

PDF Full Text (233) COI Form Open Access

Review Article

Breast cancer in pregnancy: a comprehensive review of diagnosis, management, and outcomes

Anam Mumtaz, Noor Otey, Bushra Afridi, Hazem Khout

Translational Breast Cancer Research

2024;

(30 July 2024)

PDF Full Text (262) Peer Review File COI Form Open Access

Review Article

A narrative review: research progress of adjuvant intensive endocrine therapy for early breast cancer

Hunan Ye, Guang Lin, Xiaojia Wang

Translational Breast Cancer Research

2024;

(30 July 2024)

PDF Full Text (501) Reporting Checklist Peer Review File COI Form Open Access

Original Article

Matched-pair long-term survival analysis of male and female patients with breast cancer: a population-based study

Miao Mo, Xiaoshuang Feng, Chunxiao Wu, Yangming Gong, Jie Shen, Yulian He, Changming Zhou, Zezhou Wang, Chen Fu, Ying Zheng

Translational Breast Cancer Research

2024;

(30 July 2024)

PDF Full Text (490) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Clinical Practice Guideline

Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024

Jianbin Li, Chunfang Hao, Kun Wang, Jian Zhang, Jiayi Chen, Yueping Liu, Jianyun Nie, Min Yan, Qiang Liu, Cuizhi Geng, Xiaojia Wang, Haibo Wang, Shusen Wang, Jiong Wu, Yongmei Yin, Erwei Song, Zefei Jiang

Translational Breast Cancer Research

2024;

(30 July 2024)

PDF Full Text (886) Peer Review File COI Form Open Access

Case Report

The need for a holistic guide to prevent and manage radiation dermatitis in patients’ with breast cancer: a case report

Deborah Witt Sherman

Translational Breast Cancer Research

2024;

(30 April 2024)

PDF Full Text (714) Reporting Checklist Peer Review File COI Form Open Access

Editorial Commentary

New role for GCH1 in cancer

Shane J. F. Cronin

Translational Breast Cancer Research

2024;

(30 April 2024)

PDF Full Text (539) Peer Review File COI Form Open Access

Editorial Commentary

Metabolomics combined with mathematical analysis reveals metabolic pathways specific to metastatic cancers

Shinya Sato, Toshinari Yamashita

Translational Breast Cancer Research

2024;

(30 April 2024)

PDF Full Text (420) Peer Review File COI Form Open Access

Review Article

Breast fat grafting and cancer: a systematic review of the science behind enhancements and concerns

Denis Souto Valente, Pedro Bins Ely, Lucas Kieling, Ana Terezinha Konzen, Lucas Pastori Steffen, Gloria Sulczinski Lazzaretti, Rafaela Koehler Zanella

Translational Breast Cancer Research

2024;

(30 April 2024)

PDF Full Text (1131) Reporting Checklist Peer Review File COI Form Open Access

Review Article

Breast surgery after neoadjuvant systemic therapy

Kate R. Pawloski, Andrea V. Barrio

Translational Breast Cancer Research

2024;

(30 April 2024)

PDF Full Text (984) Peer Review File COI Form Open Access

Review Article

Evolution of localization methods for non-palpable breast lesions: a literature review from a translational medicine perspective

Billy Ho Hung Cheung, Michael Co, Tsz Tsun Natalie Lui, Ava Kwong

Translational Breast Cancer Research

2024;

(30 April 2024)

PDF Full Text (1395) Reporting Checklist Peer Review File COI Form Open Access

Review Article

Internal mammary lymphadenopathy in breast cancer: a narrative review and update

Kathryn M. Eckert, Judy C. Boughey, Mara A. Piltin

Translational Breast Cancer Research

2024;

(30 April 2024)

PDF Full Text (952) Reporting Checklist Peer Review File COI Form Open Access

Review Article

Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer

Eleonora Nicolò, Caterina Gianni, Letizia Pontolillo, Mara Serena Serafini, Laura Sofia Munoz-Arcos, Eleni Andreopoulou, Giuseppe Curigliano, Carolina Reduzzi, Massimo Cristofanilli

Translational Breast Cancer Research

2024;

(30 April 2024)

PDF Full Text (1378) Peer Review File COI Form Open Access

Expert Consensus

Expert consensus on the clinical application of immunotherapy in breast cancer: 2024

Kun Wang, Jin Yang, Biyun Wang, Qiang Liu, Xiaojia Wang, Yongmei Yin, Haibo Wang, Shusen Wang, Chunfang Hao, Xiaopeng Hao, Yueping Liu, Zefei Jiang; Chinese Society of Clinical Oncology Breast Cancer Committee

Translational Breast Cancer Research

2024;

(30 April 2024)

PDF Full Text (2240) Peer Review File COI Form Open Access

Case Report

A case report of low-dose apatinib in the treatment of advanced triple-negative breast cancer

Ye Lv, Huiqiang Zhang, Yanjiao Zhao, Haixia Zhang, Tao Wang

Translational Breast Cancer Research

2024;

(31 January 2024)

PDF Full Text (956) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Poland syndrome combined with breast cancer: a case report

Shiqi Guo, Yuhui Chen, Qingyang Li, Yujiao Xie, Xiaopeng Hao, Jiandong Wang

Translational Breast Cancer Research

2024;

(31 January 2024)

PDF Full Text (851) Reporting Checklist Peer Review File COI Form Open Access

View more articles

Guideline

Chinese society of clinical oncology (CSCO) Breast Cancer Guidelines 2022

Zefei Jiang, Jianbin Li, Jiayi Chen, Yueping Liu, Kun Wang, Jianyun Nie, Xiaojia Wang, Chunfang Hao, Yongmei Yin, Shusen Wang, Min Yan, Tao Wang, Ying Yan, Xiaoyuan Chen, Erwei Song; CSCO BC guideline working group

Published online: 30 April 2022

PDF Full Text (9452) COI Form Open Access

Original Article

Pyrotinib plus capecitabine for human epidermal factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study

Min Yan, Li Bian, Xichun Hu, Qingyuan Zhang, Quchang Ouyang, Jifeng Feng, Yongmei Yin, Tao Sun, Zhongsheng Tong, Xiaojia Wang, Herui Yao, Jianjun Zou, Xiaoyu Zhu, Zefei Jiang

Published online: 30 July 2020

PDF Full Text (8529) Reporting Checklist Data Sharing Statement COI Form Open Access

Review Article

Innovation drug approvals based on a bridging study: from concept to practice

Tao Wang, Xiao Cao, Yingjian He, Xiaoyuan Chen

Published online: 31 January 2022

PDF Full Text (6035) Peer Review File COI Form Open Access

Guideline

Guidelines of Chinese Society of Clinical Oncology (CSCO) on Diagnosis and Treatment of Breast Cancer (2020 version)

Zefei Jiang, Erwei Song, Xiaojia Wang, Haibo Wang, Xiang Wang, Jiong Wu, Yongmei Yin, Qingyuan Zhang, Jiayi Chen, Wenyan Che, Xiaoyuan Chen, Zhanhong Chen, Peifen Fu, Cuizhi Geng, Baoliang Guo, Chunfang Hao, Yingjian He, Feng Jin, Ning Liao, Nanlin Li, Jian Liu, Qiang Liu, Yunjiang Liu, Yueping Liu, Jie Ma, Jianyun Nie, Yueyin Pan, Chuangui Song, Tao Sun, Kun Wang, Shu Wang, Tao Wang, Xin Wang, Biyun Wang, Shusen Wang, Yongsheng Wang, Ling Xu, Min Yan, Ying Yan, Peng Yuan, Junlan Yang, Fan Zhang, Jun Zhang, Shaohua Zhang, Xuan Zeng, Jianbin Li, Fengrui Xu

Published online: 31 October 2020

PDF Full Text (5529) COI Form Open Access

Guideline

Chinese expert consensus statement on the clinical diagnosis and treatment of breast cancer bone metastasis and bone related disease

Zefei Jiang, Haibo Wang, Shu Wang, Shusen Wang, Tao Wang, Xiaojia Wang, Jifeng Feng, Jian Liu, Qiang Liu, Tao Sun, Min Yan, Qingyuan Zhang, Jiayi Chen, Quchang Ouyang, Xichun Hu, Cuizhi Geng, Peng Yuan, Yongmei Yin, Ning Liao, Yueyin Pan

Published online: 31 January 2021

PDF Full Text (4529) Peer Review File COI Form Open Access

Review Article

A narrative review of the current landscape and future perspectives of HER2-targeting antibody drug conjugates for advanced breast cancer

Hu Li, Hongfeng Li

Published online: 31 October 2021

PDF Full Text (4534) Reporting Checklist Peer Review File COI Form Open Access

Original Article

Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes

Elena E. Sereda, Elena. S. Kolegova, Gelena V. Kakurina, Dmitriy A. Korshunov, Evgenia A. Sidenko, Artem V. Doroshenko, Elena M. Slonimskaya, Irina V. Kondakova

Published online: 30 July 2022

PDF Full Text (4233) Reporting Checklist Data Sharing Statement COI Form Open Access

Review Article

Reprogramming of fatty acid metabolism in breast cancer: a narrative review

Jin Zhao, Fei Xie, Yang Yang, Shu Wang

Published online: 31 January 2021

PDF Full Text (4124) Reporting Checklist COI Form Open Access

Original Article: Case Series

Risk-reducing surgery in PALB2 mutations carriers with breast cancer: a case series and literature review

Monika K. Masanam, Clark W. Pitcher, Olutayo Sogunro, Leah K. Starks, Allison B. Murray, Marc E. Boisvert

Published online: 31 October 2022

PDF Full Text (4020) Reporting Checklist COI Form Open Access

Original Article

Occurrence and distribution of bone metastases in 984 metastatic breast cancer patients

Huangchengyu Nie, Yang Yuan, Jianbin Li, Fengrui Xu, Tao Wang, Li Bian, Zefei Jiang, Shaohua Zhang

Published online: 31 January 2021

PDF Full Text (3866) Reporting Checklist Data Sharing Statement COI Form Open Access

Guideline

CSCO BC guideline: updates for HER2 positive breast cancer in 2020

Jianbin Li, Zefei Jiang

Published online: 10 April 2020

PDF Full Text (3512) COI form Open Access

Meet the Professor

We are on the right road | A brief history of breast cancer guidelines in China

Lili Liao

Published online: 31 July 2021

PDF Full Text (3434) Chinese (423) COI Form Open Access

Review Article

Potential biomarkers of resistance to CDK4/6 inhibitors: a narrative review of preclinical and clinical studies

Weiyi Huang, Hongxia Wang

Published online: 30 April 2021

PDF Full Text (3474) Reporting Checklist COI Form Open Access

Consensus

Expert consensus on the clinical diagnosis and targeted therapy of HER2 breast cancer (2023 edition)

Jianbin Li, Xiaojia Wang, Shusen Wang, Shu Wang, Tao Wang, Yueping Liu, Cuizhi Geng, Feng Jin, Yongmei Yin, Qingyuan Zhang, Erwei Song, Jiong Wu, Zefei Jiang; Chinese Society of Clinical Oncology Breast cancer committee; Chinese Anti-Cancer Association; Committee of Breast Cancer Society

Published online: 31 October 2022

PDF Full Text (3349) COI Form Open Access

Original Article

Analysis of the treatment patterns and safety of early breast cancer patients during the COVID-19 pandemic

Feng Li, Fengrui Xu, Huiqiang Zhang, Jianbin Li, Tao Wang, Shaohua Zhang, Li Bian, Xiaopeng Hao, Zefei Jiang

Published online: 30 July 2020

PDF Full Text (3263) Reporting Checklist Data Sharing Statement COI Form Open Access

Review Article

A narrative review of human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates in the treatment of breast cancer

Qun Li, Ye Guo, Fengjuan Lin, Lingjun Li, Xiaoxiao Ge, Wei Zhao, Jin Li

Published online: 31 October 2021

PDF Full Text (3292) Reporting Checklist COI Form Open Access

Review Article

A narrative review of the clinical development of CDK4/6 inhibitor abemaciclib in breast cancer

Liu Yang, Yang Chen, Ning Wang, Weiwei Han

Published online: 31 January 2022

PDF Full Text (3123) Reporting Checklist Peer Review File COI Form Open Access

Meet the Professor

Dr. Zefei Jiang: our journey beyond the stars and seas

Jessica Liao

Published online: 10 April 2020

PDF Full Text (3017) COI Form Open Access

Consensus

CSCO expert consensus on the diagnosis and treatment of breast cancer brain metastasis

Tao Wang, Jiayi Chen, Jin Yang, Minjie Fu, Wei Hua, Wang Jia, Yueping Liu, Biyun Wang, Min Yan, Juan Zhou, Chunfang Hao, Jiaxin Chen, Dan Ou, Tao Jiang, Ying Mao, Zefei Jiang; the CSCO expert panel of breast cancer

Published online: 30 July 2022

PDF Full Text (3000) COI Form Open Access

Consensus

Chinese expert consensus on coronavirus disease 2019 vaccination for breast cancer patients

Jianyun Nie, Tao Wang, Ruonan Xu, Jianbin Li, Yongmei Yin, Xiaojia Wang, Cuizhi Geng, Fu-Sheng Wang, Erwei Song, Zefei Jiang

Published online: 31 October 2021

PDF Full Text (2860) COI Form Open Access

Full Most Read article list >>

Review Article

Organoids in breast cancer translational research: intersection of technologies

Qimin Xu, Sangsang Zhu, Meijun Wang, Yi Zhang, Zhen Wang, Jian Huang

Published online: 09 August 2024

Journal Highlight more

Translational Breast Cancer Research is an open access, peer-reviewed journal focusing on cutting-edge development on the transition from preclinical to clinical research concerned with breast cancers, including but not limited to multidisciplinary therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances etc.